VX-670 for myotonia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Apr 2025: Trial registered, NCT06926621
  2. 28 Apr 2025: Trial started, NCT06926621

The trials

NCT06926621: A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I

State
Under way
Phase
Phase 2
People
44 planned
Started
28 Apr 2025
Primary completion
30 Jan 2029
Arms
VX-670
Results
None posted
  1. 14 Apr 2025: Trial registered
  2. 28 Apr 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.